The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

One of Monte Rosa's main differentiating factors is its proprietary QuEEN platform to design new molecular glue degraders.

India's future is being shaped by a new wave of innovative companies revolutionizing industries through technology, ...

Investors were feeling zen on Wednesday, with no major news about Donald Trump's tariffs to worry about ahead of the monthly ...

Royalty Receipts grew 12% to $729 million in the fourth quarter and 13% to $2,771 million for full year 2024, driven by strong performance from ...

Indian benchmark equity indices reduced their initial gains and were in negative territory on Thursday, influenced by ...

Following this transaction, Broadfoot now holds 31,763 shares of aTyr Pharma's common stock. Earlier, on February 3, 2025, Broadfoot acquired 3,750 shares through the vesting of RSUs, which ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and this platform has helped it generate billions of dollars in ...

The NYSE ARCA Pharmaceutical Index rose 4.3% in the past five trading sessions. Here’s how the eight major stocks performed in the previous five trading sessions. Image Source: Zacks Investment ...

Price Targets: Gaining insights, analysts provide estimates for the future value of Teva Pharmaceutical Indus's stock. This comparison reveals trends in analysts' expectations over time.

Shares of West Pharmaceutical Services Inc. WST shed 1.08% to $339.57 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0. ...